These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28879901)

  • 1.
    Kakkar A; Majumdar A; Pathak P; Kumar A; Kumari K; Tripathi M; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
    Neurol India; 2017; 65(5):1076-1082. PubMed ID: 28879901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs).
    Kakkar A; Majumdar A; Kumar A; Tripathi M; Pathak P; Sharma MC; Suri V; Tandon V; Chandra SP; Sarkar C
    Epilepsy Res; 2016 Nov; 127():141-151. PubMed ID: 27599148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.
    Prabowo AS; Iyer AM; Veersema TJ; Anink JJ; Schouten-van Meeteren AY; Spliet WG; van Rijen PC; Ferrier CH; Capper D; Thom M; Aronica E
    Brain Pathol; 2014 Jan; 24(1):52-66. PubMed ID: 23941441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas.
    Martinoni M; Marucci G; de Biase D; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Tallini G; Giulioni M
    J Clin Neurosci; 2015 Aug; 22(8):1250-3. PubMed ID: 25937573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
    Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
    [No Abstract]   [Full Text] [Related]  

  • 6. The genetic landscape of ganglioglioma.
    Pekmezci M; Villanueva-Meyer JE; Goode B; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Chamyan G; Maher OM; Khatib Z; Kleinschmidt-DeMasters BK; Samuel D; Mueller S; Banerjee A; Clarke JL; Cooney T; Torkildson J; Gupta N; Theodosopoulos P; Chang EF; Berger M; Bollen AW; Perry A; Tihan T; Solomon DA
    Acta Neuropathol Commun; 2018 Jun; 6(1):47. PubMed ID: 29880043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
    Pagès M; Beccaria K; Boddaert N; Saffroy R; Besnard A; Castel D; Fina F; Barets D; Barret E; Lacroix L; Bielle F; Andreiuolo F; Tauziède-Espariat A; Figarella-Branger D; Puget S; Grill J; Chrétien F; Varlet P
    Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors.
    Shen CH; Zhang YX; Xu JH; Zhu QB; Zhu JM; Guo Y; Ding Y; Wang S; Ding MP
    Epilepsy Res; 2017 Sep; 135():123-130. PubMed ID: 28667867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
    Schindler G; Capper D; Meyer J; Janzarik W; Omran H; Herold-Mende C; Schmieder K; Wesseling P; Mawrin C; Hasselblatt M; Louis DN; Korshunov A; Pfister S; Hartmann C; Paulus W; Reifenberger G; von Deimling A
    Acta Neuropathol; 2011 Mar; 121(3):397-405. PubMed ID: 21274720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells.
    Koelsche C; Wöhrer A; Jeibmann A; Schittenhelm J; Schindler G; Preusser M; Lasitschka F; von Deimling A; Capper D
    Acta Neuropathol; 2013 Jun; 125(6):891-900. PubMed ID: 23435618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test.
    Durślewicz J; Klimaszewska-Wiśniewska A; Antosik P; Kasperska A; Grzanka D; Szylberg T; Szylberg Ł
    Dis Markers; 2020; 2020():8880548. PubMed ID: 32879641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status.
    Lindsay AJ; Rush SZ; Fenton LZ
    J Neurooncol; 2014 Jun; 118(2):395-404. PubMed ID: 24792487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
    Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
    Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoplastic non-infantile astrocytoma/ganglioglioma: rare low-grade tumor with frequent BRAF V600E mutation.
    Chatterjee D; Garg C; Singla N; Radotra BD
    Hum Pathol; 2018 Oct; 80():186-191. PubMed ID: 29902580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.
    Donson AM; Kleinschmidt-DeMasters BK; Aisner DL; Bemis LT; Birks DK; Levy JM; Smith AA; Handler MH; Foreman NK; Rush SZ
    Brain Pathol; 2014 Mar; 24(2):173-83. PubMed ID: 24238153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors.
    Breton Q; Plouhinec H; Prunier-Mirebeau D; Boisselier B; Michalak S; Menei P; Rousseau A
    Brain Behav; 2017 Mar; 7(3):e00641. PubMed ID: 28293477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression.
    Chappé C; Padovani L; Scavarda D; Forest F; Nanni-Metellus I; Loundou A; Mercurio S; Fina F; Lena G; Colin C; Figarella-Branger D
    Brain Pathol; 2013 Sep; 23(5):574-83. PubMed ID: 23442159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cellular gene expression in ganglioglioma.
    Samadani U; Judkins AR; Akpalu A; Aronica E; Crino PB
    Epilepsia; 2007 Apr; 48(4):646-53. PubMed ID: 17437409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy Outcome and Pathology Analysis for Ganglioglioma: A Series of 51 Pediatric Patients.
    Liu Q; Cai L; Sun Y; Wang Y; Yu H; Liu C; Wang H; Zhang S; Gong J
    Pediatr Neurol; 2023 Dec; 149():127-133. PubMed ID: 37879136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilocytic astrocytoma vs. ganglioglioma: Progression vs. misdiagnosis, and implications in BRAF testing.
    Yoon J; Cusimano M; Munoz DG
    J Clin Neurosci; 2019 Aug; 66():231-234. PubMed ID: 31147230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.